Caffeine–hydrazones as anticancer agents with pronounced selectivity toward T-lymphoblastic leukaemia cells
- 1 June 2015
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 60, 19-29
Abstract
No abstract availableKeywords
Funding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy (CZ.1.07/2.3.00/30.0041, CZ.1.07/2.3.00/30.0060)
- European Social Fund Plus (LO1304)
- Technology Agency of the Czech Republic (TE01020028)
This publication has 25 references indexed in Scilit:
- Synthesis and Significant Cytostatic Activity of 7-Hetaryl-7-deazaadenosinesJournal of Medicinal Chemistry, 2011
- 1-Hydrazinophthalazine based hydrazones and their transition metal complexes: Structure and biological activityRussian Journal of General Chemistry, 2009
- Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agentsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Polystyrene-Supported Iodobenzene Diacetate (PSIBD)–Mediated Synthesis of 1,2-Diacylbenzenes from 2-Hydroxyaryl Aldehyde/Ketone AcylhydrazonesSynthetic Communications, 2008
- Biological Activities of Hydrazone DerivativesMolecules, 2007
- Future of ToxicologyIron Chelators and Differing Modes of Action and Toxicity: The Changing Face of Iron Chelation TherapyChemical Research in Toxicology, 2007
- Synthesis, Structure−Activity Relationships, and Antitumor Studies of 2-Benzoxazolyl Hydrazones Derived from Alpha-(N)-acyl HeteroaromaticsJournal of Medicinal Chemistry, 2006
- The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and CancerPharmacological Reviews, 2005
- Kondensationen von Aldehyden und Ketonen mit 8‐Hydrazino‐coffeinArchiv der Pharmazie, 1956
- 8‐Hydrazino‐purine und ihre Überführung in PyrazoloneEuropean Journal of Inorganic Chemistry, 1955